[1] Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016; 64, 73−84. doi:  10.1002/hep.28431
[2] Chinese Physician Association of Fatty Liver Disease Expert Committee. Guidelines for the prevention and treatment of nonalcoholic fatty liver disease (2018 update). Infectious disease information, 2018; 31, 393−402. (In Chinese)
[3] Li L, Liu DW, Yan HY, et al. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev, 2016; 17, 510−9. doi:  10.1111/obr.12407
[4] Kitamoto T, Kitamoto A, Yoneda M, et al. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum Genet, 2013; 132, 783−92. doi:  10.1007/s00439-013-1294-3
[5] Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology, 2011; 140, 124−31. doi:  10.1053/j.gastro.2010.09.038
[6] Arienti V, Pretolani S, Accogli E, et al. Ultrasonography (US) and non-invasive diagnostic methods for non-alcoholic fatty liver disease (NAFLD) and early vascular damage. Possible application in a population study on the metabolic syndrome (MS). Internal & Emergency Medicine, 2012; 7, 283−90.
[7] Xu J, Yang Y, Liu X, et al. Genetic variation and significant association of polymorphism rs7700944 G>A of TIM-4 gene with rheumatoid arthritis susceptibility in Chinese Han and Hui populations. Int J Immunogenet, 2012; 39, 409−13. doi:  10.1111/j.1744-313X.2012.01103.x
[8] Zhang W, Zhu LQ, Huo XL, et al. Association of adiponectin gene polymorphisms and additional gene-gene interaction with nonalcoholic fatty liver disease in the Chinese Han population. Hepatol Int, 2016; 10, 511−7. doi:  10.1007/s12072-015-9687-0
[9] Miele L, Dall'Armi V, Cefalo C, et al. A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease. Genes Nutr, 2014; 9, 1−10.
[10] Assuncao S, Sorte N, Alves C, et al. Inflammatory cytokines and non-alcoholic fatty liver disease (NAFLD) in obese children and adolescents. Nutr Hosp, 2018; 35, 78−83.